Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation
暂无分享,去创建一个
K. Nitta | M. Kuro-o | H. Kurosu | K. Yamagata | T. Kishi | R. Kaneda | S. Maeda | T. Onaka | K. Kosaki | Kazunori Karasawa | K. Shiizaki | Masahiro Matsui | Yutaka Miura | T. Nakano | Shoya Mori | Naoki Usui | Masahide Yoshida | Hiroaki Mizukami | Keisei Kosaki